Gary E. Gallick
Impact in
- Oncology top 0.2%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 21
- Angiogenesis and VEGF in Cancer 19
- Oncology 91
- Bone health and treatments 20
- HER2/EGFR in Cancer Research 18
- Colorectal Cancer Treatments and Studies 16
- Co-authors
- Nila U. Parikh (38 shared papers)Lee M. Ellis (21 shared papers)Justin M. Summy (18 shared papers)James L. Abbruzzese (6 shared papers)Wenbiao Liu (10 shared papers)Douglas B. Evans (8 shared papers)Huamin Wang (4 shared papers)Serk In Park (7 shared papers)
- Journals
- Cancer Research (20 papers)Journal of Clinical Oncology (11 papers)Oncogene (8 papers)Clinical Cancer Research (8 papers)Journal of Cellular Physiology (5 papers)
- Partner nations
- United StatesSpainTaiwan
In The Last Decade
Gary E. Gallick
204 papers receiving 13.5k citations
Gary E. Gallick's Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 5.2k
- Cancer Research 2.5k
- Immunology and Allergy 807
- Hematology 1.1k
- Molecular Biology 6.9k
Countries citing papers authored by Gary E. Gallick
This map shows the geographic impact of Gary E. Gallick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Gallick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Gallick more than expected).
Fields of papers citing papers by Gary E. Gallick
This network shows the impact of papers produced by Gary E. Gallick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Gallick. The network helps show where Gary E. Gallick may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary E. Gallick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 204 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer Hit paper breakdown → | 2009 | 733 |
| 2 | BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571 Hit paper breakdown → | 2002 | 530 |
| 3 | Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway Hit paper breakdown → | 2009 | 529 |
| 4 | 2007 | 366 | |
| 5 | 1993 | 352 | |
| 6 | 2005 | 325 | |
| 7 | 2009 | 279 | |
| 8 | 2001 | 270 | |
| 9 | 2017 | 251 | |
| 10 | 2012 | 235 | |
| 11 | 2011 | 226 | |
| 12 | 2002 | 213 | |
| 13 | 2008 | 188 | |
| 14 | 2001 | 179 | |
| 15 | 2005 | 176 | |
| 16 | 2002 | 173 | |
| 17 | 1998 | 169 | |
| 18 | 2008 | 168 | |
| 19 | 2006 | 168 | |
| 20 | 2006 | 166 |
About Gary E. Gallick
Gary E. Gallick is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Cell Biology, having authored 204 papers that have together received 13.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), PI3K/AKT/mTOR signaling in cancer (21 papers), Bone health and treatments (20 papers), Angiogenesis and VEGF in Cancer (19 papers), HER2/EGFR in Cancer Research (18 papers), Colorectal Cancer Treatments and Studies (16 papers), Cell Adhesion Molecules Research (16 papers) and Cancer, Hypoxia, and Metabolism (16 papers). The work is most often cited by research in Oncology (5.2k citations), Cancer Research (2.5k citations), Immunology and Allergy (807 citations), Hematology (1.1k citations) and Molecular Biology (6.9k citations). Gary E. Gallick has collaborated with scholars based in United States, Spain and Taiwan. Frequent co-authors include Nila U. Parikh, Lee M. Ellis, Justin M. Summy, James L. Abbruzzese, Wenbiao Liu, Douglas B. Evans, Huamin Wang, Serk In Park, Ami N. Shah and David J. McConkey. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Oncogene, Clinical Cancer Research and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.